ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Potter Resigns As director Of Lombardi Cancer Center; Search Committee To Look for Successor

July 24, 1987

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999

Technology Isolates and Recovers Circulating Liver Tumor Cells

April 27, 2012

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013